rs186780639
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_005422.4(TECTA):c.3511G>A(p.Val1171Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00024 in 1,613,716 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.3511G>A | p.Val1171Met | missense_variant | 11/24 | 5 | NM_005422.4 | ENSP00000376543.1 | ||
TECTA | ENST00000264037.2 | c.3511G>A | p.Val1171Met | missense_variant | 10/23 | 1 | ENSP00000264037.2 | |||
TECTA | ENST00000642222.1 | c.3511G>A | p.Val1171Met | missense_variant | 11/24 | ENSP00000493855.1 | ||||
TECTA | ENST00000645008.1 | c.817G>A | p.Val273Met | missense_variant | 2/15 | ENSP00000496274.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152228Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000234 AC: 58AN: 247956Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134302
GnomAD4 exome AF: 0.000248 AC: 363AN: 1461370Hom.: 2 Cov.: 32 AF XY: 0.000237 AC XY: 172AN XY: 726868
GnomAD4 genome AF: 0.000158 AC: 24AN: 152346Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74490
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 17, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2021 | Identified in patients with hearing loss in published literature, although specific genotype and phenotype information were not provided for the affected individuals (Miyagawa et al., 2013; Chen et al., 2016); Reported as a non-pathogenic variant without additional details (Yamamoto et al., 2017; Azaiez et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; Located in the von Willebrand factor type D3 region of the zonadhesin domain (Hildebrand et al., 2011); This variant is associated with the following publications: (PMID: 30245029, 28946916, 27610647, 23967202) - |
Autosomal recessive nonsyndromic hearing loss 21 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 07, 2016 | p.Val1171Met in exon 10 of TECTA: This variant is not expected to have clinical significance because it has been identified in 0.4% (33/8586) of East Asian chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs186780639). - |
Autosomal dominant nonsyndromic hearing loss 12 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at